Lightcast Discovery
25 Nov, 2024
The Broers Building, JJ Thomson Avenue, Cambridge. Credit: Scott Gilbert Photography.
Empowering biological discoveries, Lightcast has invented a novel single-cell functional analysis technology platform that facilitates the functional analysis of individual cells by using rays of light to control picoliter-scale droplets.
Its scalable platform for scientists has the flexibility to analyse multiple cell types and assays with precision, and it can process and analyse up to hundreds of thousands of individual cells simultaneously.
Headquartered in Cambridge, UK, Lightcast opened a new Innovation Centre and laboratory in Cambridge, Mass., in 2024 to meet the high demand from its North American collaborators.
In Q3 2023, Lighcast raised a $49m Series B round led by M Ventures, the VC arm of Merck.
Briony Quested